UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of Earliest Event Reported): | May 6, 2010 |
Charles River Laboratories International, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
| Delaware | 001-15943 | 06-1397316 |
| _____________________ (State or other jurisdiction | _____________ (Commission | ______________ (I.R.S. Employer |
| of incorporation) | File Number) | Identification No.) |
| 251 Ballardvale St., Wilmington, Massachusetts | 01887 | |
| _________________________________ (Address of principal executive offices) | ___________ (Zip Code) |
| Registrant’s telephone number, including area code: | 978-658-6000 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07. Submission of Matters to a Vote of Security Holders
Charles River Laboratories International, Inc. (the “Company”) held its Annual Meeting of Shareholders on May 6, 2010, For more information on the following proposals, see the Company’s proxy statement dated March 30, 2010. At the Annual Meeting the proposals were adopted by the votes specified below:
| (a) | The following directors were elected to serve until the Company’s 2011 Annual Meeting of Shareholders and received the number of votes listed opposite each of their names below: |
| Number of | Number of | |||||||||||
| Shares Voted For | Shares Withheld | Broker Non-Votes | ||||||||||
| James C. Foster | 53,187,221 | 2,418,975 | 2,146,907 | |||||||||
| Nancy T. Chang | 43,962,929 | 11,643,267 | 2,146,907 | |||||||||
| Stephen D. Chubb | 52,346,043 | 3,260,153 | 2,146,907 | |||||||||
| Deborah T. Kochevar. | 46,828,226 | 8,777,970 | 2,146,907 | |||||||||
| George E. Massaro | 53,221,956 | 2,384,240 | 2,146,907 | |||||||||
| George M. Milne, Jr. | 43,848,036 | 11,758,160 | 2,146,907 | |||||||||
| C. Richard Reese | 54,356,225 | 1,249,971 | 2,146,907 | |||||||||
| Douglas E. Rogers | 44,229,172 | 11,377,024 | 2,146,907 | |||||||||
| Samuel O. Thier | 54,310,604 | 1,295,592 | 2,146,907 | |||||||||
| William H. Waltrip | 42,972,092 | 12,634,104 | 2,146,907 | |||||||||
| (b) | The ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditors for fiscal 2010. A total of 55,846,976 shares voted in favor of the ratification, 1,696,529 shares voted against the ratification, and 209,598 shares abstained from voting. There were no broker non-votes for this proposal. |
Computershare Trust Company, N.A., our transfer agent, acted as independent proxy tabulator and Inspector of Election at the Annual Meeting of Shareholders.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Charles River Laboratories International, Inc. | ||||
| May 11, 2010 | By: | Matthew L. Daniel | ||
| Name: Matthew L. Daniel | ||||
| Title: Deputy General Counsel and Assistant Secretary | ||||